Rani Therapeutics Holdings, Inc. Annual Current Income Tax Expense (Benefit) in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Rani Therapeutics Holdings, Inc. annual Current Income Tax Expense (Benefit) history and growth rate from 2020 to 2022.
  • Rani Therapeutics Holdings, Inc. annual Current Income Tax Expense (Benefit) for 2022 was $70K, a 70.7% increase from 2021.
  • Rani Therapeutics Holdings, Inc. annual Current Income Tax Expense (Benefit) for 2021 was $41K, a 17.1% increase from 2020.
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $70K +$29K +70.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-22
2021 $41K +$6K +17.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $35K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.